Top

Published in:

01-12-2016 | Understanding the Disease

Understanding why resistant bacteria are associated with higher mortality in ICU patients

Authors: François Barbier, Thiago Lisboa, Saad Nseir

Published in: Intensive Care Medicine | Issue 12/2016

Excerpt

The incidence of infections related to multidrug-resistant (MDR) bacteria is high in the ICU. Based on the results of the large multinational EPIC II study, MDR bacteria represented 36 % of microorganisms identified in patients with confirmed infection [1]. The main risk factors for resistance are prior exposure to antibiotics, prolonged hospital and ICU length of stay (LOS), invasive devices, comorbidities and local epidemiology [2‐4]. …

Vincent J-L, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329CrossRefPubMed

Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289CrossRefPubMed

Martin-Loeches I, Deja M, Koulenti D et al (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681CrossRefPubMed

Bassetti M, De Waele JJ, Eggimann P et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795CrossRefPubMed

Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME (2013) Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect 66:401–414CrossRefPubMed

Zilberberg MD, Shorr AF (2011) Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU. Curr Opin Infect Dis 24:385–389CrossRefPubMed

Tabah A, Koulenti D, Laupland K et al (2012) Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38:1930–1945CrossRefPubMed

Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60:913–920CrossRefPubMed

Garnacho-Montero J, Dimopoulos G, Poulakou G et al (2015) Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med 41:2057–2075CrossRefPubMed

10.

Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65:2658–2665CrossRefPubMed

11.

Combes A, Luyt C-E, Fagon J-Y et al (2004) Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia. Am J Respir Crit Care Med 170:786–792CrossRefPubMed

12.

Spapen H, Jacobs R, Van Gorp V et al (2011) Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 1:14CrossRefPubMedPubMedCentral

13.

Ruppé É, Woerther P-L, Barbier F (2015) Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 5:61CrossRefPubMed

14.

Lisboa T, Diaz E, Sa-Borges M et al (2008) The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest 134:1208–1216CrossRefPubMed

15.

Zahar JR, Garrouste-Orgeas M, Vesin A et al (2013) Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 39:2153–2160CrossRefPubMed

16.

Sawa T, Shimizu M, Moriyama K, Wiener-Kronish JP (2014) Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Crit Care 18:668CrossRefPubMedPubMedCentral

Title: Understanding why resistant bacteria are associated with higher mortality in ICU patients
Authors: François Barbier
Thiago Lisboa
Saad Nseir
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 12/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-015-4138-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Understanding why resistant bacteria are associated with higher mortality in ICU patients

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2016

In memoriam: Johan Groeneveld

Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

What’s new in sepsis recognition in resource-limited settings?

Understanding clinical signs of poor tissue perfusion during septic shock

In 2035, will all bacteria be multidrug resistant? We are not sure

Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial